AI assistant
Amphastar Pharmaceuticals, Inc. — Director's Dealing 2021
Jan 20, 2021
10216_dirs_2021-01-20_d3b88022-591c-4035-a1c1-7aa5cb52d1c6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2021-01-19
Reporting Person: PETERS WILLIAM J (CFO, SVP & Treasurer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-01-19 | Common Stock | S | 6495 | $18.6662 | Disposed | 89548 | Direct |
Footnotes
F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2020.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.545 to $18.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F3: Includes 391 shares acquired under the Issuer's 2014 Employee Stock Purchase Plan on November 30, 2020.